Study Title

68Ga-NOTA-3P-TATE-RGD for Dual Somatostatin Receptor and Integrin αvβ3 PET/CT Imaging of Lung Cancer and Neuroendocrine Neoplams

Study Details

Description:

This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the diagnostic performance and evaluate the efficacy of 68Ga-NOTA-3PTATE-RGD in lung cancer patients and neuroendocrine neoplam patients. A single dose of 111-185 Mega-Becquerel (MBq) 68Ga-NOTA-3P-TATE-RGD will be injected intravenously. Visual and semiquantitative method will be used to assess the PET/CT images.

Contacts:

Zhaohui Zhu, MD

13611093752@163.com

+8613611093752

Shaobo Yao, PhD

yaoshaobo008@163.com

+8618301511895

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468